Mbio Pharmaceuticals, Inc. is a publicly traded company trading on XNAS, led by CEO Ka Chun Lam, with a market cap of $108.4M.
Common questions about Mbio Pharmaceuticals, Inc.
Mbio Pharmaceuticals, Inc. (MB) has a market capitalization of $108.4M and trades on XNAS.